|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 400 out of 419 for Tpo

0.302s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: de Laval B
Year: 2014
Journal: Blood
Title: Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1.
Volume: 123
Issue: 4
Pages: 509-19
Publication
First Author: Tong W
Year: 2004
Journal: J Exp Med
Title: Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Volume: 200
Issue: 5
Pages: 569-80
Publication
First Author: Bersenev A
Year: 2008
Journal: J Clin Invest
Title: Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2.
Volume: 118
Issue: 8
Pages: 2832-44
Publication
First Author: Chan ER
Year: 2009
Journal: Exp Hematol
Title: An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance.
Volume: 37
Issue: 2
Pages: 276-84
Publication
First Author: Rodriguez W
Year: 2012
Journal: PLoS One
Title: Deletion of the RNaseIII enzyme dicer in thyroid follicular cells causes hypothyroidism with signs of neoplastic alterations.
Volume: 7
Issue: 1
Pages: e29929
Publication
First Author: Au AE
Year: 2017
Journal: Sci Rep
Title: Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling.
Volume: 7
Issue: 1
Pages: 14953
Publication
First Author: Sangkhae V
Year: 2014
Journal: Blood
Title: The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.
Volume: 124
Issue: 26
Pages: 3956-63
Publication  
First Author: Hacein-Bey-Abina S
Year: 2020
Journal: Exp Hematol
Title: Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
Volume: 88
Pages: 15-27
Publication
First Author: Rozenova K
Year: 2015
Journal: Blood
Title: MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling.
Volume: 125
Issue: 11
Pages: 1730-8
Publication
First Author: Bunting S
Year: 1997
Journal: Blood
Title: Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Volume: 90
Issue: 9
Pages: 3423-9
Publication
First Author: Carver-Moore K
Year: 1996
Journal: Blood
Title: Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.
Volume: 88
Issue: 3
Pages: 803-8
Publication
First Author: Fielder PJ
Year: 1996
Journal: Blood
Title: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.
Volume: 87
Issue: 6
Pages: 2154-61
Publication
First Author: Tan W
Year: 2013
Journal: J Leukoc Biol
Title: Requirement of TPO/c-mpl for IL-17A-induced granulopoiesis and megakaryopoiesis.
Volume: 94
Issue: 6
Pages: 1303-8
Publication
First Author: Amano H
Year: 2005
Journal: Circ Res
Title: Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia.
Volume: 97
Issue: 4
Pages: 337-45
Publication
First Author: Luoh SM
Year: 2000
Journal: Mol Cell Biol
Title: Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
Volume: 20
Issue: 2
Pages: 507-15
Publication
First Author: Alexander WS
Year: 1996
Journal: Blood
Title: Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
Volume: 87
Issue: 6
Pages: 2162-70
Publication
First Author: Lannutti BJ
Year: 2009
Journal: Blood
Title: Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
Volume: 113
Issue: 8
Pages: 1778-85
Publication
First Author: Kimura S
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.
Volume: 95
Issue: 3
Pages: 1195-200
Publication
First Author: Misharin AV
Year: 2009
Journal: Endocrinology
Title: Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.
Volume: 150
Issue: 6
Pages: 2948-56
Publication
First Author: Kirito K
Year: 2005
Journal: Blood
Title: Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha.
Volume: 105
Issue: 11
Pages: 4258-63
Publication
First Author: Meinders M
Year: 2016
Journal: PLoS One
Title: Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment.
Volume: 11
Issue: 5
Pages: e0154342
Publication
First Author: Hitchcock IS
Year: 2008
Journal: Blood
Title: Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.
Volume: 111
Issue: 2
Pages: 596-604
Publication
First Author: Du J
Year: 2012
Journal: Stem Cells
Title: Signaling profiling at the single-cell level identifies a distinct signaling signature in murine hematopoietic stem cells.
Volume: 30
Issue: 7
Pages: 1447-54
Publication
First Author: Kosone T
Year: 2007
Journal: Lab Invest
Title: Hepatocyte growth factor accelerates thrombopoiesis in transgenic mice.
Volume: 87
Issue: 3
Pages: 284-91
Publication
First Author: Moore SF
Year: 2019
Journal: Sci Rep
Title: Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function.
Volume: 9
Issue: 1
Pages: 1468
Publication
First Author: Gostynska S
Year: 2022
Journal: Blood Adv
Title: Megakaryocyte/platelet-derived TGF-β1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver.
Volume: 6
Issue: 11
Pages: 3321-3328
Publication
First Author: Hong SH
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Rescue of a primary myelofibrosis model by retinoid-antagonist therapy.
Volume: 110
Issue: 47
Pages: 18820-5
Publication
First Author: Pecquet C
Year: 2012
Journal: Blood
Title: Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes.
Volume: 119
Issue: 20
Pages: 4625-35
Publication
First Author: Xie X
Year: 2003
Journal: Blood
Title: Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs.
Volume: 101
Issue: 4
Pages: 1329-35
Publication
First Author: Tonelli R
Year: 2000
Journal: Hum Genet
Title: Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT).
Volume: 107
Issue: 3
Pages: 225-33
Publication
First Author: Foster DC
Year: 1994
Journal: Proc Natl Acad Sci U S A
Title: Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.
Volume: 91
Issue: 26
Pages: 13023-7
Publication
First Author: Kaushansky K
Year: 1995
Journal: Proc Natl Acad Sci U S A
Title: Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.
Volume: 92
Issue: 8
Pages: 3234-8
Publication
First Author: Pallard C
Year: 1995
Journal: EMBO J
Title: Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
Volume: 14
Issue: 12
Pages: 2847-56
Publication
First Author: Kato T
Year: 1995
Journal: J Biochem
Title: Purification and characterization of thrombopoietin.
Volume: 118
Issue: 1
Pages: 229-36
Publication
First Author: Stoffel R
Year: 1996
Journal: Blood
Title: Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets.
Volume: 87
Issue: 2
Pages: 567-73
Publication
First Author: Porteu F
Year: 1996
Journal: Mol Cell Biol
Title: Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
Volume: 16
Issue: 5
Pages: 2473-82
Publication
First Author: Van Renterghem P
Year: 1996
Journal: Biochim Biophys Acta
Title: Pax 8 expression in primary cultured dog thyrocyte is increased by cyclic AMP.
Volume: 1307
Issue: 1
Pages: 97-103
Publication
First Author: Yan XQ
Year: 1996
Journal: Blood
Title: A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation.
Volume: 88
Issue: 2
Pages: 402-9
Publication
First Author: Ku H
Year: 1996
Journal: Blood
Title: Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2.
Volume: 88
Issue: 11
Pages: 4124-31
Publication
First Author: Hoshi S
Year: 1997
Journal: Biochem Biophys Res Commun
Title: Megakaryocytopoietic activity of a truncated variant of mouse thrombopoietin.
Volume: 231
Issue: 3
Pages: 823-6
Publication
First Author: Nagata Y
Year: 1997
Journal: Blood
Title: Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3.
Volume: 89
Issue: 8
Pages: 2664-9
Publication
First Author: Nomura S
Year: 1997
Journal: Exp Hematol
Title: Cellular localization of thrombopoietin mRNA in the liver by in situ hybridization.
Volume: 25
Issue: 7
Pages: 565-72
Publication
First Author: Wakikawa T
Year: 1997
Journal: Endocrinology
Title: Thrombopoietin inhibits in vitro osteoclastogenesis from murine bone marrow cells.
Volume: 138
Issue: 10
Pages: 4160-6
Publication
First Author: Cardier JE
Year: 1998
Journal: Blood
Title: Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells.
Volume: 91
Issue: 3
Pages: 923-9
Publication
First Author: Frey BM
Year: 1998
Journal: J Immunol
Title: Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
Volume: 160
Issue: 2
Pages: 691-9
Publication
First Author: Kotani T
Year: 1999
Journal: J Endocrinol
Title: A novel mutation in the human thyroid peroxidase gene resulting in a total iodide organification defect.
Volume: 160
Issue: 2
Pages: 267-73
Publication
First Author: Hayward SL
Year: 2007
Journal: J Immunol Methods
Title: A radioligand binding assay to measure anti-thyroperoxidase autoantibodies in mice.
Volume: 323
Issue: 2
Pages: 114-22
Publication
First Author: Sohn BH
Year: 1999
Journal: DNA Cell Biol
Title: Expression and characterization of bioactive human thrombopoietin in the milk of transgenic mice.
Volume: 18
Issue: 11
Pages: 845-52
Publication
First Author: Kirito K
Year: 2002
Journal: Blood
Title: A functional role of Stat3 in in vivo megakaryopoiesis.
Volume: 99
Issue: 9
Pages: 3220-7
Publication
First Author: Hitchcock IS
Year: 2008
Journal: Blood
Title: YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation.
Volume: 112
Issue: 6
Pages: 2222-31
Publication
First Author: Eguchi M
Year: 2008
Journal: J Mol Cell Cardiol
Title: Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6kinase signaling pathway.
Volume: 45
Issue: 5
Pages: 661-9
Publication
First Author: Tiedt R
Year: 2009
Journal: Blood
Title: Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
Volume: 113
Issue: 8
Pages: 1768-77
Publication
First Author: Saur SJ
Year: 2010
Journal: Blood
Title: Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.
Volume: 115
Issue: 6
Pages: 1254-63
Publication
First Author: Huang X
Year: 2009
Journal: Genes Cells
Title: Thrombopoietin controls proliferation of embryonic multipotent hematopoietic progenitors.
Volume: 14
Issue: 7
Pages: 851-60
Publication
First Author: Bishton MJ
Year: 2011
Journal: Blood
Title: Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.
Volume: 117
Issue: 13
Pages: 3658-68
Publication
First Author: Schaap-Oziemlak AM
Year: 2013
Journal: PLoS One
Title: Wnt5a does not support hematopoiesis in stroma-free, serum-free cultures.
Volume: 8
Issue: 1
Pages: e53669
Publication
First Author: Machlus KR
Year: 2017
Journal: Blood
Title: Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.
Volume: 130
Issue: 9
Pages: 1132-1143
Publication
First Author: Donaghy R
Year: 2019
Journal: Blood
Title: The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination.
Volume: 133
Issue: 14
Pages: 1560-1571
Publication
First Author: Morodomi Y
Year: 2020
Journal: Blood
Title: Mechanisms of anti-GPIbα antibody-induced thrombocytopenia in mice.
Volume: 135
Issue: 25
Pages: 2292-2301
Publication
First Author: Chen X
Year: 2021
Journal: Theranostics
Title: Aurka loss in CD19(+) B cells promotes megakaryocytopoiesis via IL-6/STAT3 signaling-mediated thrombopoietin production.
Volume: 11
Issue: 10
Pages: 4655-4671
Publication
First Author: Morino-Koga S
Year: 2024
Journal: Proc Natl Acad Sci U S A
Title: Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells.
Volume: 121
Issue: 31
Pages: e2404193121
Publication
First Author: Tong W
Year: 2007
Journal: Exp Hematol
Title: Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.
Volume: 35
Issue: 9
Pages: 1447-55
Publication
First Author: Fleury M
Year: 2010
Journal: Int J Dev Biol
Title: Mpl receptor defect leads to earlier appearance of hematopoietic cells/hematopoietic stem cells in the Aorta-Gonad-Mesonephros region, with increased apoptosis.
Volume: 54
Issue: 6-7
Pages: 1067-74
Publication
First Author: Levin J
Year: 2001
Journal: Blood
Title: Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response.
Volume: 98
Issue: 4
Pages: 1019-27
Publication
First Author: McLachlan SM
Year: 2019
Journal: Thyroid
Title: A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
Volume: 29
Issue: 8
Pages: 1138-1146
Publication
First Author: McLachlan SM
Year: 2017
Journal: Endocrinology
Title: Variable Effects of Dietary Selenium in Mice That Spontaneously Develop a Spectrum of Thyroid Autoantibodies.
Volume: 158
Issue: 11
Pages: 3754-3764
Publication
First Author: Ogasawara M
Year: 2000
Journal: Dev Genes Evol
Title: Overlapping expression of amphioxus homologs of the thyroid transcription factor-1 gene and thyroid peroxidase gene in the endostyle: insight into evolution of the thyroid gland.
Volume: 210
Issue: 5
Pages: 231-42
Publication
First Author: Villeval JL
Year: 1997
Journal: Blood
Title: High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice.
Volume: 90
Issue: 11
Pages: 4369-83
Publication
First Author: Yang FC
Year: 1999
Journal: Blood
Title: Differential effects of human granulocyte colony-stimulating factor (hG-CSF) and thrombopoietin on megakaryopoiesis and platelet function in hG-CSF receptor-transgenic mice.
Volume: 94
Issue: 3
Pages: 950-8
Publication
First Author: Barroga CF
Year: 2008
Journal: Exp Hematol
Title: Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression.
Volume: 36
Issue: 12
Pages: 1585-92
Publication
First Author: Castillo GM
Year: 2017
Journal: PLoS One
Title: Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.
Volume: 12
Issue: 2
Pages: e0171703
Publication  
First Author: Josa V
Year: 2020
Journal: Int J Mol Sci
Title: Thrombocytosis and Effects of IL-6 Knock-Out in a Colitis-Associated Cancer Model.
Volume: 21
Issue: 17
Protein
Organism: Mus musculus/domesticus
Length: 145  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 99  
Fragment?: true
Protein Domain
Type: Family
Description: Peroxidases are haem-containing enzymes that use hydrogen peroxide as the electron acceptor to catalyse a number of oxidative reactions.Peroxidases are found in bacteria, fungi, plants and animals. On the basis of sequence similarity, a number of animal haem peroxidases can be categorised as members of a superfamily: myeloperoxidase (MPO); eosinophil peroxidase (EPO); lactoperoxidase (LPO); thyroid peroxidase (TPO); prostaglandin H synthase (PGHS); and peroxidasin [, , ]. MPO plays a major role in the oxygen-dependent microbicidal system of neutrophils. EPO from eosinophilic granulocytes participates in immunological reactions, and potentiates tumor necrosis factor (TNF) production and hydrogen peroxide release by human monocyte-derived macrophages [, ]. In the main, MPO (and possibly EPO) utilises Cl-ions and H2O2to form hypochlorous acid (HOCl), which can effectively kill bacteria or parasites. In secreted fluids, LPO catalyses the oxidation of thiocyanate ions (SCN-) by H2O2, producing the weak oxidising agent hypothiocyanite (OSCN-), which has bacteriostatic activity []. TPO uses I-ions and H2O2to generate iodine, and plays a central role in the biosynthesis of thyroid hormones T(3) and T(4). To date, the 3D structures of MPO and PGHS have been reported. MPO is a homodimer: each monomer consists of a light (A or B) and a heavy (C or D) chain resulting from post-translational excision of 6 residues from the common precursor. Monomers are linked by a single inter-chain disulphide. Each monomer includes a bound calcium ion []. PGHS exists as a symmetric dimer, each monomer of which consists of 3 domains: an N-terminal epidermal growth factor (EGF) like module; a membrane-binding domain; and a large C-terminal catalytic domain containing the cyclooxygenase and the peroxidase active sites. The catalytic domain shows striking structural similarity to MPO. The cyclooxygenase active site, which catalyses the formation of prostaglandin G2 (PGG2) from arachidonic acid, resides at the apex of a long hydrophobic channel, extending from the membrane-binding domain to the centre of the molecule. The peroxidase active site, which catalyses the reduction of PGG2 to PGH2, is located on the other side of the molecule, at the haem binding site []. Both MPO and the catalytic domain of PGHS are mainly α-helical, 19 helices being identified as topologically and spatially equivalent; PGHS contains 5 additional N-terminal helices that have no equivalent in MPO. In both proteins, three Asn residues in each monomer are glycosylated.
Protein Domain
Type: Homologous_superfamily
Description: Peroxidases are haem-containing enzymes that use hydrogen peroxide as the electron acceptor to catalyse a number of oxidative reactions.Peroxidases are found in bacteria, fungi, plants and animals. On the basis of sequence similarity, a number of animal haem peroxidases can be categorised as members of a superfamily: myeloperoxidase (MPO); eosinophil peroxidase (EPO); lactoperoxidase (LPO); thyroid peroxidase (TPO); prostaglandin H synthase (PGHS); and peroxidasin [, , ]. MPO plays a major role in the oxygen-dependent microbicidal system of neutrophils. EPO from eosinophilic granulocytes participates in immunological reactions, and potentiates tumor necrosis factor (TNF) production and hydrogen peroxide release by human monocyte-derived macrophages [, ]. In the main, MPO (and possibly EPO) utilises Cl-ions and H2O2to form hypochlorous acid (HOCl), which can effectively kill bacteria or parasites. In secreted fluids, LPO catalyses the oxidation of thiocyanate ions (SCN-) by H2O2, producing the weak oxidising agent hypothiocyanite (OSCN-), which has bacteriostatic activity []. TPO uses I-ions and H2O2to generate iodine, and plays a central role in the biosynthesis of thyroid hormones T(3) and T(4). To date, the 3D structures of MPO and PGHS have been reported. MPO is a homodimer: each monomer consists of a light (A or B) and a heavy (C or D) chain resulting from post-translational excision of 6 residues from the common precursor. Monomers are linked by a single inter-chain disulphide. Each monomer includes a bound calcium ion []. PGHS exists as a symmetric dimer, each monomer of which consists of 3 domains: an N-terminal epidermal growth factor (EGF) like module; a membrane-binding domain; and a large C-terminal catalytic domain containing the cyclooxygenase and the peroxidase active sites. The catalytic domain shows striking structural similarity to MPO. The cyclooxygenase active site, which catalyses the formation of prostaglandin G2 (PGG2) from arachidonic acid, resides at the apex of a long hydrophobic channel, extending from the membrane-binding domain to the centre of the molecule. The peroxidase active site, which catalyses the reduction of PGG2 to PGH2, is located on the other side of the molecule, at the haem binding site []. Both MPO and the catalytic domain of PGHS are mainly α-helical, 19 helices being identified as topologically and spatially equivalent; PGHS contains 5 additional N-terminal helices that have no equivalent in MPO. In both proteins, three Asn residues in each monomer are glycosylated.
Protein
Organism: Mus musculus/domesticus
Length: 718  
Fragment?: false
Publication
First Author: Shoemaker CB
Year: 1986
Journal: Mol Cell Biol
Title: Murine erythropoietin gene: cloning, expression, and human gene homology.
Volume: 6
Issue: 3
Pages: 849-58
Protein
Organism: Mus musculus/domesticus
Length: 192  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 192  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 718  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 166  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 710  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 718  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 183  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 710  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 718  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 138  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 191  
Fragment?: false
Publication
First Author: Kimura S
Year: 1989
Journal: Biochemistry
Title: Structure of the human thyroid peroxidase gene: comparison and relationship to the human myeloperoxidase gene.
Volume: 28
Issue: 10
Pages: 4481-9
Publication
First Author: Wever R
Year: 1982
Journal: Biochim Biophys Acta
Title: The peroxidation of thiocyanate catalysed by myeloperoxidase and lactoperoxidase.
Volume: 709
Issue: 2
Pages: 212-9
Publication
First Author: Spessotto P
Year: 1995
Journal: Eur J Immunol
Title: Human eosinophil peroxidase enhances tumor necrosis factor and hydrogen peroxide release by human monocyte-derived macrophages.
Volume: 25
Issue: 5
Pages: 1366-73
Publication
First Author: Zeng J
Year: 1992
Journal: J Mol Biol
Title: X-ray crystal structure of canine myeloperoxidase at 3 A resolution.
Volume: 226
Issue: 1
Pages: 185-207
Publication
First Author: Picot D
Year: 1994
Journal: Nature
Title: The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1.
Volume: 367
Issue: 6460
Pages: 243-9
Publication
First Author: Kimura S
Year: 1988
Journal: Proteins
Title: Human myeloperoxidase and thyroid peroxidase, two enzymes with separate and distinct physiological functions, are evolutionarily related members of the same gene family.
Volume: 3
Issue: 2
Pages: 113-20
Publication  
First Author: Martinez ME
Year: 2023
Journal: Front Endocrinol (Lausanne)
Title: Paternal developmental thyrotoxicosis disrupts neonatal leptin leading to increased adiposity and altered physiology of the melanocortin system.
Volume: 14
Pages: 1210414
Protein
Organism: Mus musculus/domesticus
Length: 62  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 716  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 602  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 604  
Fragment?: false